Huberman LabDr. Tony Wyss-Coray on Huberman Lab: How blood resets aging
Parabiosis cut inflammation in aged mice via young blood factors; blood protein panels now assign organ age gaps that predict disease risk years before.
CHAPTERS
Young blood and parabiosis: reactivating the aged brain
Wyss-Coray describes how heterochronic parabiosis (joining circulation of young and old mice) revealed that circulating factors from young organisms can rejuvenate old tissues, including the brain. In old mice exposed to young blood, neural stem cells reactivate, inflammation decreases, neural activity improves, and memory performance increases.
Blood as more than a readout: biomarkers that may drive aging and disease
The conversation shifts from blood as a diagnostic window to blood as a causal influencer of organ function. Large-scale proteomics shows dramatic age-related shifts in thousands of circulating proteins, raising the question of which factors are drivers versus consequences of aging and neurodegeneration.
Human translation: plasma fractions, Alzheimer’s trials, and plasma exchange
Wyss-Coray explains attempts to translate mouse findings into human studies, including injecting human plasma into mice and testing clinical-grade plasma fractions. He reviews early trials in Alzheimer’s/Parkinson’s and highlights therapeutic plasma exchange (TPE) studies suggesting possible cognitive/functional benefits.
What’s in “young blood”: removing harmful inflammation vs adding pro-youth factors
They unpack whether benefits come from diluting/removing age-related “bad” factors, adding “good” youth factors, or both. Wyss-Coray describes inflammatory proteins that rise with age and can be neutralized in mice, alongside growth and stem-cell-supporting factors that promote repair.
Blood banking, Dracula lore, and historical blood practices
Huberman asks whether individuals should bank their blood and whether cultural myths like Dracula reflect intuitive knowledge about blood and vitality. Wyss-Coray argues pooled young plasma works in studies, reducing the need for personal banking, and notes there’s no evidence that drinking blood would reproduce transfusion-like effects.
Organs age at different rates: protein-based organ clocks and disease risk
Wyss-Coray describes how organs and even cell types can age asynchronously. Using proteins in blood that originate from specific organs, his group builds ‘organ age’ estimates and shows that an ‘age gap’ (organ older than chronological age) predicts future disease risk in that organ.
Personalized prevention platform: tailoring interventions and monitoring response
The discussion covers how organ-age readouts could guide individualized interventions—medications, exercise, diet, or other lifestyle changes—then retest to see whether the targeted organ ‘gets younger.’ This approach also speaks to why many drugs fail: heterogeneity in disease subtypes and late intervention timing.
NAD, NMN/NR supplements, and what the evidence does (and doesn’t) show
Huberman asks directly about NAD-boosting strategies and longevity claims. Wyss-Coray notes there’s no validated human intervention proven to extend lifespan, highlights that supplements may raise blood levels without proving clinical outcomes, and cautions about product instability and label inaccuracies.
Vitality vs longevity and ‘waves’ of accelerated aging across adulthood
They explore antagonistic pleiotropy—traits beneficial early in life may be harmful later. Wyss-Coray discusses ‘waves of aging’ in blood proteins, with a major inflection around ~35–40, and considers evolutionary explanations for why maintenance programs may weaken after reproductive years.
Exercise as a blood-borne brain therapy: liver signals, clustrin, and intensity questions
Wyss-Coray describes experiments showing that blood from exercised animals transfers some brain benefits to sedentary recipients, and that exercised young blood may outperform young blood alone. He highlights liver-derived factors such as clustrin and other candidates, while noting mechanisms remain complex and multifactorial.
Injury, inflammation, and the risks of unproven regenerative injections
They discuss why healing declines with age, emphasizing immune aging, chronic inflammation, and extracellular matrix changes that impair repair. Huberman and Wyss-Coray caution against unregulated stem-cell injections, highlighting infection and severe adverse outcomes, and contrast these with more established approaches.
PRP and exosomes: what they are and what’s plausible
Wyss-Coray explains platelet-rich plasma (PRP) as an autologous concentrate of platelet growth factors used for wound healing and some injuries. He describes exosomes as vesicles carrying proteins/RNA/lipids that may mediate intercellular signaling and could be useful diagnostically or therapeutically, though clinical evidence varies.
Environment, diet quality, and fasting: cautious interpretation of longevity claims
They review cumulative exposure concerns (plastics, pesticides, EMFs) and the practical difficulty of isolating long-term effects. On fasting, Wyss-Coray emphasizes inconsistent definitions and mixed animal data, with limited compelling human trial evidence, while agreeing that constant snacking is likely maladaptive.
Sleep, CSF rejuvenation, and synaptic protein predictors of cognitive resilience
Wyss-Coray discusses how cerebrospinal fluid (CSF) composition changes with age and can influence brain function. He describes experiments infusing young CSF into old mice to improve cognition and myelination-related cells, and human CSF proteomics identifying synaptic protein signatures that strongly predict cognitive resilience independent of classic pathology markers.
Lifestyle, social connection, light exposure, and future directions: cell-type aging clocks & genetic disease proteome maps
They connect established dementia risk modifiers (smoking, alcohol excess, education, obesity, poverty) with the need for mechanistic, personalized tools. Wyss-Coray previews new work estimating aging of specific cell types from blood proteins and describes a major project to map plasma proteome changes across monogenic diseases to infer pathways and disease relationships.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome